Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

View:
Post by bluemoons20 on May 23, 2023 12:07pm

Winning??

Good  question  about  what  winning looks  like.

Might be interesting to speculate,  what it means  for the share  price.  Does  it mean  we stay  here?  Go  to  0.20  ?  go  to  $5   or  to  $20  ??   And what  could be the longer term  prospects   -  continue to  languish   or???

GLTA
Comment by Ingiboy on May 23, 2023 4:27pm
bluemoons20 there are endless outcomes that are possible and each having a projected share price: Replicel and Shiseido strike a deal to co-develop RCH-01. Shiseido buys out the rights to RCH-01. Shiseido buys out Replicel. Replicel wins the Arbitration and recovers the marketing rights for RCH-01 in Asia Replicel wins the arbitration, recovers the marketing rights to RCH-01 in Asia and awarded a ...more  
Comment by bluemoons20 on May 25, 2023 10:37am
Agree that there are lots of possibilities.  Was  just  wondering  if anyone  wanted to guess  what  any outcome  might mean to the share price.  (would not hold anyone to their guess). Heard  some people  say  0.20  and then  hope  for at least 0.50  and  your  comment about $3  tops. Just thought it ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities